
|Articles|August 1, 2017
- Pharmaceutical Executive-08-01-2017
- Volume 37
- Issue 8
Pharmaceutical Executive, August 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Health Policy Problem Solver: Fumie Griegoalmost 9 years ago
Dealmaking in 2017: Striking a Balancealmost 9 years ago
Beyond the Science: Commercial Implications From ASCO 2017almost 9 years ago
News Spotlight: Pharmaalmost 9 years ago
Pharma’s Marijuana Makeoveralmost 9 years ago
The 'Hear' and Now for Pharma and Social Mediaalmost 9 years ago
Pressure Mounts on FDA, Pharma to Tackle Opioid Abusealmost 9 years ago
Syncing Social Media With Value-Care Modelalmost 9 years ago
AI-based Social Listening as Aid to Pharmacovigilancealmost 9 years ago
Country Report: IndonesiaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
3
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
4
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
5




